Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Magellan Awarded China Approval for Blood Lead Test

publication date: Aug 12, 2016
Magellan Diagnostics, a Boston area medical device company, received CFDA clearance to market its LeadCare® II Blood Lead Testing System in China. Using two drops of blood, the portable system quantifies the lead level in a person's blood in three minutes. The system is intended for use in clinics and doctors' offices. Because high levels of lead are known to retard children's development, the system is aimed primarily at parents who fear their children are at risk. Magellen was acquired by Meridian Bioscience, a diagnostics company, for $66 million earlier this year. More details....

Stock Symbol: (NSDQ: VIVO)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital